P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S106
Author(s):  
Yukito Ichinose ◽  
Yoshiki Takada ◽  
Kaoru Matsui ◽  
Akihiro Bessho ◽  
Shinzo Kudoh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Thoracic Radiotherapy ◽  
Small Cell Lung ◽  
Limited Disease

A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study

Lung Cancer ◽  
1993 ◽  
Vol 10 (1-2) ◽  
pp. 85-89
Author(s):  
Nicholas A. Pavlidis ◽  
George Klouvas ◽  
Costas Nicolaides ◽  
Apostolos Karantanas ◽  
Marios Beer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Oncology Group Study

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

2006 ◽  
Vol 1 (9) ◽  
pp. 996-1001 ◽  
Author(s):  
Primo N. Lara ◽  
Kari Chansky ◽  
Angela M. Davies ◽  
Wilbur A. Franklin ◽  
Paul H. Gumerlock ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Southwest Oncology Group ◽  
Extensive Stage
Sign in / Sign up

Export Citation Format

Share Document